Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
Clinical trial NCT03391973 · COMPLETED
Trial details
- NCT number
- NCT03391973
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2023-06-16
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.